Celldex Therapeutics, Inc.
CLDX
$30.26
$1.726.03%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -28.50% | -22.85% | -21.44% | -18.27% | 71.22% |
| Total Receivables | 187.86% | -89.44% | -94.13% | -60.16% | -73.36% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -33.53% | -4.39% | 121.28% | 120.30% | 287.38% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -28.44% | -22.41% | -20.14% | -16.95% | 73.08% |
|
|
|||||
| Total Current Assets | -28.44% | -22.41% | -20.14% | -16.95% | 73.08% |
| Net Property, Plant & Equipment | -5.74% | 1.97% | 18.99% | 30.34% | 24.21% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 37.05% | -3.93% | 8,591.59% | 9,628.04% | 9,009.35% |
| Total Assets | -26.42% | -21.23% | -18.12% | -14.89% | 70.17% |
|
|
|||||
| Total Accounts Payable | -63.86% | 283.03% | -45.48% | 5.44% | -6.55% |
| Total Accrued Expenses | 38.97% | 40.81% | 52.87% | 45.16% | 53.62% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 6.89% | 12.62% | -3.34% | -8.82% | -10.04% |
| Total Finance Division Other Current Liabilities | 30.57% | -33.38% | -74.68% | -57.36% | -76.38% |
| Total Other Current Liabilities | 30.57% | -33.38% | -74.68% | -57.36% | -76.38% |
| Total Current Liabilities | 29.09% | 44.78% | 19.18% | 21.78% | 26.91% |
|
|
|||||
| Total Current Liabilities | 29.09% | 44.78% | 19.18% | 21.78% | 26.91% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -66.79% | -37.47% | 87.81% | 310.43% | 154.42% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 16.41% | -26.78% | -26.78% | -26.78% | -21.12% |
| Total Liabilities | 23.12% | 34.35% | 15.89% | 20.69% | 24.36% |
|
|
|||||
| Common Stock & APIC | 1.68% | 1.68% | 1.75% | 1.85% | 26.09% |
| Retained Earnings | -16.64% | -14.89% | -13.62% | -12.51% | -11.30% |
| Treasury Stock & Other | 9.41% | -28.80% | 87.58% | 59.00% | 0.18% |
| Total Common Equity | -29.43% | -23.86% | -19.45% | -16.17% | 74.06% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -29.43% | -23.86% | -19.45% | -16.17% | 74.06% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -29.43% | -23.86% | -19.45% | -16.17% | 74.06% |
|
|
|||||